Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Okun

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Dermatological Treatment|August 17, 2023
Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancerMarco Boeri, Maral K Skelsey, James A Schiro, et al.
Acta Dermato-Venereologica|August 8, 2018
Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and IIAlexandra B Kimball, Thrasivoulos Tzellos, Brian M Calimlim, et al.
JAMA|July 5, 1985
Transcutaneous temporary pacing in the operating roomD Berliner, M Okun, R W Peters, et al.
The Journal of Dermatological Treatment|March 17, 2007
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trialRichard Shikiar, Michael Heffernan, Richard G Langley, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 27, 2005
Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolinesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
European Journal of Medicinal Chemistry|September 20, 2005
Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-dionesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
The Journal of Dermatology|June 30, 2015
Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese studyAkihiko Asahina, Mamitaro Ohtsuki, Takafumi Etoh, et al.
General Physiology and Biophysics|June 1, 1986
Inactivation of muscarinic acetylcholine receptors in brain synaptic membranes by free fatty acids. Evaluation of the role of lipid phaseI M Okun, N V Merezhinskaya, A A Rakovich, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indolesAlexandre V Ivachtchenko, Eugen B Frolov, Oleg D Mitkin, et al.
General Physiology and Biophysics|August 1, 1991
On the mechanism of shrinkage-induced potassium influx in rat and human erythrocytesS N Orlov, N I Pokudin, T G Gurlo, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Dermatological Treatment|August 17, 2023
Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancerMarco Boeri, Maral K Skelsey, James A Schiro, et al.
Acta Dermato-Venereologica|August 8, 2018
Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and IIAlexandra B Kimball, Thrasivoulos Tzellos, Brian M Calimlim, et al.
JAMA|July 5, 1985
Transcutaneous temporary pacing in the operating roomD Berliner, M Okun, R W Peters, et al.
The Journal of Dermatological Treatment|March 17, 2007
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trialRichard Shikiar, Michael Heffernan, Richard G Langley, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 27, 2005
Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolinesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
European Journal of Medicinal Chemistry|September 20, 2005
Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-dionesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
The Journal of Dermatology|June 30, 2015
Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese studyAkihiko Asahina, Mamitaro Ohtsuki, Takafumi Etoh, et al.
General Physiology and Biophysics|June 1, 1986
Inactivation of muscarinic acetylcholine receptors in brain synaptic membranes by free fatty acids. Evaluation of the role of lipid phaseI M Okun, N V Merezhinskaya, A A Rakovich, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indolesAlexandre V Ivachtchenko, Eugen B Frolov, Oleg D Mitkin, et al.
General Physiology and Biophysics|August 1, 1991
On the mechanism of shrinkage-induced potassium influx in rat and human erythrocytesS N Orlov, N I Pokudin, T G Gurlo, et al.
Pageof 11